DK164407B - Modificerede nucleotider og fremgangsmaader til deres fremstilling, fremgangsmaade til paavisning af et dobbeltstrenget polynucleotidduplex indeholdende et modificeret nucleotid, fremgangsmaade til bestemmelse af tilstedevaerelsen af et deoxyribonucleinsyremolekyle eller et ribonucleinsyremolekyle, fremgangsmaade til test af en bakterie, fremgangsmaade til diagnosticering af en genetisk forstyrrelse, fre - Google Patents

Modificerede nucleotider og fremgangsmaader til deres fremstilling, fremgangsmaade til paavisning af et dobbeltstrenget polynucleotidduplex indeholdende et modificeret nucleotid, fremgangsmaade til bestemmelse af tilstedevaerelsen af et deoxyribonucleinsyremolekyle eller et ribonucleinsyremolekyle, fremgangsmaade til test af en bakterie, fremgangsmaade til diagnosticering af en genetisk forstyrrelse, fre Download PDF

Info

Publication number: DK164407B
Authority: DK; Denmark
Prior art keywords: complex; double; purine; polynucleotide; compound
Prior art date: 1981-04-17

Application number

DK171382A

Other languages

Danish (da)

English (en)

Other versions

DK171382A (da

Inventor

David C Ward

Pennina R Langer-Safer

Iii Alexander A Waldrop

Original Assignee

Univ Yale

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-04-17

Filing date

1982-04-16

Publication date

1992-06-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22967380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK164407(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1982-04-16 Application filed by Univ Yale filed Critical Univ Yale

1982-10-18 Publication of DK171382A publication Critical patent/DK171382A/da

1992-06-22 Publication of DK164407B publication Critical patent/DK164407B/da

Links

108020004414 DNA Proteins 0.000 title claims abstract description 49
238000001514 detection method Methods 0.000 title claims abstract description 34
102000053602 DNA Human genes 0.000 title claims abstract description 27
241000894006 Bacteria Species 0.000 title claims abstract description 19
208000026350 Inborn Genetic disease Diseases 0.000 title claims abstract description 12
208000016361 genetic disease Diseases 0.000 title claims abstract description 12
238000000034 method Methods 0.000 title claims description 94
238000002360 preparation method Methods 0.000 title claims description 10
230000008569 process Effects 0.000 title claims description 8
238000003745 diagnosis Methods 0.000 title abstract description 6
125000003729 nucleotide group Chemical group 0.000 title description 38
238000012360 testing method Methods 0.000 title description 5
102000040430 polynucleotide Human genes 0.000 claims abstract description 73
108091033319 polynucleotide Proteins 0.000 claims abstract description 73
239000002157 polynucleotide Substances 0.000 claims abstract description 73
150000001875 compounds Chemical class 0.000 claims abstract description 57
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims abstract description 46
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 45
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 45
229920001184 polypeptide Polymers 0.000 claims abstract description 44
210000000349 chromosome Anatomy 0.000 claims abstract description 40
150000007523 nucleic acids Chemical class 0.000 claims abstract description 25
210000004027 cell Anatomy 0.000 claims abstract description 21
102000039446 nucleic acids Human genes 0.000 claims abstract description 20
108020004707 nucleic acids Proteins 0.000 claims abstract description 20
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims abstract description 19
125000000714 pyrimidinyl group Chemical group 0.000 claims abstract description 17
229920002477 rna polymer Polymers 0.000 claims abstract description 15
239000000126 substance Substances 0.000 claims abstract description 12
125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
230000002759 chromosomal effect Effects 0.000 claims abstract description 6
-1 7-deazapurine Chemical group 0.000 claims abstract description 4
108090000623 proteins and genes Proteins 0.000 claims description 30
239000002773 nucleotide Substances 0.000 claims description 20
230000003115 biocidal effect Effects 0.000 claims description 15
230000015572 biosynthetic process Effects 0.000 claims description 14
238000006243 chemical reaction Methods 0.000 claims description 14
230000027455 binding Effects 0.000 claims description 11
230000000295 complement effect Effects 0.000 claims description 11
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 9
210000004881 tumor cell Anatomy 0.000 claims description 9
230000002068 genetic effect Effects 0.000 claims description 6
230000035945 sensitivity Effects 0.000 claims description 6
238000006872 enzymatic polymerization reaction Methods 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 5
239000002253 acid Substances 0.000 claims description 4
239000003125 aqueous solvent Substances 0.000 claims description 4
125000000524 functional group Chemical group 0.000 claims description 4
238000003780 insertion Methods 0.000 claims description 3
230000037431 insertion Effects 0.000 claims description 3
239000001226 triphosphate Substances 0.000 claims description 3
235000011178 triphosphate Nutrition 0.000 claims description 3
101150003085 Pdcl gene Proteins 0.000 claims description 2
239000003242 anti bacterial agent Substances 0.000 claims description 2
150000003839 salts Chemical class 0.000 claims description 2
239000002904 solvent Substances 0.000 claims description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
239000013067 intermediate product Substances 0.000 claims 1
210000004940 nucleus Anatomy 0.000 claims 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
239000000523 sample Substances 0.000 abstract description 45
108091034117 Oligonucleotide Proteins 0.000 abstract description 10
230000004807 localization Effects 0.000 abstract description 4
241000700605 Viruses Species 0.000 abstract description 3
239000003795 chemical substances by application Substances 0.000 abstract description 3
241000233866 Fungi Species 0.000 abstract description 2
238000003759 clinical diagnosis Methods 0.000 abstract description 2
239000000284 extract Substances 0.000 abstract description 2
210000001519 tissue Anatomy 0.000 abstract description 2
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 54
239000011616 biotin Substances 0.000 description 29
229960002685 biotin Drugs 0.000 description 29
235000020958 biotin Nutrition 0.000 description 27
238000009396 hybridization Methods 0.000 description 23
108010090804 Streptavidin Proteins 0.000 description 21
108090001008 Avidin Proteins 0.000 description 17
235000018102 proteins Nutrition 0.000 description 14
102000004169 proteins and genes Human genes 0.000 description 14
102000004190 Enzymes Human genes 0.000 description 10
108090000790 Enzymes Proteins 0.000 description 10
230000001745 anti-biotin effect Effects 0.000 description 9
239000003153 chemical reaction reagent Substances 0.000 description 9
238000007901 in situ hybridization Methods 0.000 description 9
230000008901 benefit Effects 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 7
238000013507 mapping Methods 0.000 description 7
108040007629 peroxidase activity proteins Proteins 0.000 description 7
102000013415 peroxidase activity proteins Human genes 0.000 description 7
108010078791 Carrier Proteins Proteins 0.000 description 6
102000014914 Carrier Proteins Human genes 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 6
238000005516 engineering process Methods 0.000 description 6
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 6
239000007850 fluorescent dye Substances 0.000 description 6
230000002285 radioactive effect Effects 0.000 description 6
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 5
108020004511 Recombinant DNA Proteins 0.000 description 5
230000001744 histochemical effect Effects 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
DEQPBRIACBATHE-FXQIFTODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-2-iminopentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCC(=N)C(=O)O)SC[C@@H]21 DEQPBRIACBATHE-FXQIFTODSA-N 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
239000003446 ligand Substances 0.000 description 4
238000011160 research Methods 0.000 description 4
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
108010077544 Chromatin Proteins 0.000 description 3
239000003298 DNA probe Substances 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
238000008416 Ferritin Methods 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
102000002067 Protein Subunits Human genes 0.000 description 3
108010001267 Protein Subunits Proteins 0.000 description 3
108020004487 Satellite DNA Proteins 0.000 description 3
241000191967 Staphylococcus aureus Species 0.000 description 3
208000002903 Thalassemia Diseases 0.000 description 3
230000003321 amplification Effects 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
210000003483 chromatin Anatomy 0.000 description 3
230000002559 cytogenic effect Effects 0.000 description 3
238000000151 deposition Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
239000012634 fragment Substances 0.000 description 3
239000011521 glass Substances 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
238000010166 immunofluorescence Methods 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000000463 material Substances 0.000 description 3
230000031864 metaphase Effects 0.000 description 3
230000009871 nonspecific binding Effects 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
239000012857 radioactive material Substances 0.000 description 3
125000001424 substituent group Chemical group 0.000 description 3
239000000758 substrate Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
102000008857 Ferritin Human genes 0.000 description 2
108050000784 Ferritin Proteins 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
102000009572 RNA Polymerase II Human genes 0.000 description 2
108010009460 RNA Polymerase II Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
241000193996 Streptococcus pyogenes Species 0.000 description 2
241000186983 Streptomyces avidinii Species 0.000 description 2
108010034949 Thyroglobulin Proteins 0.000 description 2
102000009843 Thyroglobulin Human genes 0.000 description 2
231100000071 abnormal chromosome number Toxicity 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
238000013459 approach Methods 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
244000309466 calf Species 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
238000007374 clinical diagnostic method Methods 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
108060003552 hemocyanin Proteins 0.000 description 2
210000003917 human chromosome Anatomy 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
238000002372 labelling Methods 0.000 description 2
230000037361 pathway Effects 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
230000003252 repetitive effect Effects 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
241000894007 species Species 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
229960002175 thyroglobulin Drugs 0.000 description 2
238000013519 translation Methods 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
238000012800 visualization Methods 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
241000566113 Branta sandvicensis Species 0.000 description 1
COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
201000010374 Down Syndrome Diseases 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
241000701832 Enterobacteria phage T3 Species 0.000 description 1
241000701533 Escherichia virus T4 Species 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
206010018612 Gonorrhoea Diseases 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
241000588650 Neisseria meningitidis Species 0.000 description 1
206010029719 Nonspecific reaction Diseases 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
101710171342 Peroxidase 35 Proteins 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
102000014450 RNA Polymerase III Human genes 0.000 description 1
108010078067 RNA Polymerase III Proteins 0.000 description 1
101710086015 RNA ligase Proteins 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Chemical class Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
IYKNGWWPNRDDHK-ONEGZZNKSA-N [[5-[2,4-dioxo-5-[(e)-3-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]prop-1-enyl]pyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)CC1N1C(=O)NC(=O)C(\C=C\CNC(=O)CCCCC2C3NC(=O)NC3CS2)=C1 IYKNGWWPNRDDHK-ONEGZZNKSA-N 0.000 description 1
WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
150000001615 biotins Chemical class 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
108091092356 cellular DNA Proteins 0.000 description 1
241000902900 cellular organisms Species 0.000 description 1
210000002230 centromere Anatomy 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
230000014107 chromosome localization Effects 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000010668 complexation reaction Methods 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
230000023077 detection of light stimulus Effects 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
235000014103 egg white Nutrition 0.000 description 1
210000000969 egg white Anatomy 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
229960003699 evans blue Drugs 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
238000002795 fluorescence method Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
238000007429 general method Methods 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
150000002338 glycosides Chemical class 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
238000003505 heat denaturation Methods 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
238000013095 identification testing Methods 0.000 description 1
238000005286 illumination Methods 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000003125 immunofluorescent labeling Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
239000011630 iodine Substances 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
235000019136 lipoic acid Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000000415 mammalian chromosome Anatomy 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical group [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
244000045947 parasite Species 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
210000003055 polytene chromosome Anatomy 0.000 description 1
238000003793 prenatal diagnosis Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
238000000746 purification Methods 0.000 description 1
108700022487 rRNA Genes Proteins 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
239000002689 soil Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
210000001768 subcellular fraction Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
229960002663 thioctic acid Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Pathology (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK171382A 1981-04-17 1982-04-16 Modificerede nucleotider og fremgangsmaader til deres fremstilling, fremgangsmaade til paavisning af et dobbeltstrenget polynucleotidduplex indeholdende et modificeret nucleotid, fremgangsmaade til bestemmelse af tilstedevaerelsen af et deoxyribonucleinsyremolekyle eller et ribonucleinsyremolekyle, fremgangsmaade til test af en bakterie, fremgangsmaade til diagnosticering af en genetisk forstyrrelse, fre DK164407B (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25522381A	1981-04-17	1981-04-17
US25522381		1981-04-17

Publications (2)

Publication Number	Publication Date
DK171382A DK171382A (da)	1982-10-18
DK164407B true DK164407B (da)	1992-06-22

Family

ID=22967380

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK171382A DK164407B (da)	1981-04-17	1982-04-16	Modificerede nucleotider og fremgangsmaader til deres fremstilling, fremgangsmaade til paavisning af et dobbeltstrenget polynucleotidduplex indeholdende et modificeret nucleotid, fremgangsmaade til bestemmelse af tilstedevaerelsen af et deoxyribonucleinsyremolekyle eller et ribonucleinsyremolekyle, fremgangsmaade til test af en bakterie, fremgangsmaade til diagnosticering af en genetisk forstyrrelse, fre
DK160591A DK171822B1 (da)	1981-04-17	1991-09-16	Modificerede nucleotider og fremgangsmåder til deres fremstilling og påvisning
DK046797A DK46797A (da)	1981-04-17	1997-04-28	Modificerede oligo- og polynucleotider og fremgangsmåder til deres fremstilling og påvisning

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK160591A DK171822B1 (da)	1981-04-17	1991-09-16	Modificerede nucleotider og fremgangsmåder til deres fremstilling og påvisning
DK046797A DK46797A (da)	1981-04-17	1997-04-28	Modificerede oligo- og polynucleotider og fremgangsmåder til deres fremstilling og påvisning

Country Status (8)

Country	Link
EP (1)	EP0063879B1 (de)
JP (6)	JPS57209297A (de)
AT (1)	ATE167189T1 (de)
AU (1)	AU560651B2 (de)
CA (1)	CA1219824A (de)
DE (2)	DE3280032D1 (de)
DK (3)	DK164407B (de)
IL (1)	IL65447A (de)

Families Citing this family (190)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1219824A (en) *	1981-04-17	1987-03-31	David C. Ward	Modified nucleotides and methods of preparing and using same
FI63596C (fi) *	1981-10-16	1983-07-11	Orion Yhtymae Oy	Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
DK105582A (da) *	1982-03-11	1983-09-12	Nordisk Insulinlab	Fremgangsmaade til bestemmelse af humane hla-d(r) vaevstyper og gensonde til brug ved fremgangsmaaden
US7220854B1 (en)	1982-06-23	2007-05-22	Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc.	Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides
US5241060A (en) *	1982-06-23	1993-08-31	Enzo Diagnostics, Inc.	Base moiety-labeled detectable nucleatide
CA1223831A (en)	1982-06-23	1987-07-07	Dean Engelhardt	Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US5260433A (en) *	1982-06-23	1993-11-09	Enzo Diagnostics, Inc.	Saccharide specific binding system labeled nucleotides
EP0148356B1 (de) *	1982-09-30	1990-12-05	Aktiebolaget Iro	Garnspeicher- und Zuführvorrichtung
US4689295A (en) *	1983-01-20	1987-08-25	Integrated Genetics, Inc.	Test for Salmonella
US4994373A (en)	1983-01-27	1991-02-19	Enzo Biochem, Inc.	Method and structures employing chemically-labelled polynucleotide probes
FR2540122B1 (fr) *	1983-01-27	1985-11-29	Centre Nat Rech Scient	Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
CA1309672C (en) *	1983-01-27	1992-11-03	Jannis G. Stavrianopoulos	Methods and structures employing non-radioactive chemically-labeled polynucleotide probes
US4605735A (en) *	1983-02-14	1986-08-12	Wakunaga Seiyaku Kabushiki Kaisha	Oligonucleotide derivatives
JPS59148798A (ja) *	1983-02-14	1984-08-25	Wakunaga Seiyaku Kk	ビオチンヌクレオチド誘導体
US4948882A (en) *	1983-02-22	1990-08-14	Syngene, Inc.	Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
EP0135587B2 (de) *	1983-02-22	2002-12-18	Syngene, Inc.	Einzelstrang-oligonukleotide bestimmter sequenz, markergruppen enthaltend, verfahren zu deren chemischer synthese und nukleotide zur verwendung darin
CA1254525A (en) *	1983-04-13	1989-05-23	Christine L. Brakel	Kit for terminally chemically labeling dna
ES8600404A1 (es) *	1983-05-02	1985-10-01	Enzo Biochem Inc	Un metodo para detectar una secuencia seleccionada de acido nucleico en un material biologico.
CA1228811A (en) *	1983-05-05	1987-11-03	Robert G. Pergolizzi	Assay method utilizing polynucleotide sequences
DE3485811T2 (de) *	1983-05-31	1993-01-07	Orgenics Ltd	Molekulare genetische sonde und verfahren zu ihrer herstellung, testmethode und satz in denen diese molekulare genetische sonde gebraucht wird.
US5221609A (en) *	1983-05-31	1993-06-22	Orgenics Ltd.	Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe
CA1222705A (en) *	1983-07-14	1987-06-09	Molecular Diagnostics, Inc.	Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US4959309A (en) *	1983-07-14	1990-09-25	Molecular Diagnostics, Inc.	Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US4623627A (en)	1983-08-19	1986-11-18	Cetus Corporation	Monoclonal antibody having specificity for the double-stranded conformation of native DNA and diagnostic methods using same
NO843838L (no) *	1983-09-26	1985-03-27	Ortho Diagnostic Systems Inc	Fremgangsmaate for detektering av nukleinsyre
FR2555606B1 (fr) *	1983-11-24	1986-10-24	Pasteur Institut	Sonde non radio-active et procede pour la caracterisation d'une sequence nucleotidique determinee et moyens pour la production de cette sonde non radio-active
WO1985002415A1 (fr) *	1983-11-24	1985-06-06	Institut Pasteur	Sonde non radioactive et procede pour la caracterisation d'une sequence nucleotidique determinee et moyens pour la production de cette sonde non radioactive
IL73580A0 (en) *	1983-12-12	1985-02-28	Miles Lab	Hybridization assay employing labeled pairs of hybrid binding reagents
EP0144913A3 (de) *	1983-12-12	1986-08-20	Miles Inc.	Hybridisierungstest mittels einer markierten Probe und Anti-Hybrid
IL73578A (en) *	1983-12-12	1989-09-28	Miles Lab	Method and reagent for the detection of polynucleotide sequence in sample of dna or rna by using a nucleic acid probe and contact of duplexes with immobilizing antibody
EP0144914A3 (de) *	1983-12-12	1986-08-13	Miles Inc.	Hybridisierungstest mittels markierter Paare von hybridbindenden Reagenzien
EP0146039A3 (de) *	1983-12-12	1986-08-27	Miles Inc.	Hybridisierungstest mit Immobilisierung von Hybriden mittels Antihybridbindung
US4743535A (en) *	1984-11-07	1988-05-10	Miles Inc.	Hybridization assay employing labeled probe and anti-hybrid
EP0149339B1 (de) *	1983-12-16	1989-08-23	MediSense, Inc.	Test für Nukleinsäuren
US4849513A (en) *	1983-12-20	1989-07-18	California Institute Of Technology	Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
JPH0690200B2 (ja) *	1984-01-16	1994-11-14	カリフオルニア・インステイテユ−ト・オブ・テクノロジ−	オリゴヌクレオチドの分析法
US5821058A (en) *	1984-01-16	1998-10-13	California Institute Of Technology	Automated DNA sequencing technique
USRE43096E1 (en)	1984-01-16	2012-01-10	California Institute Of Technology	Tagged extendable primers and extension products
US4699876A (en) *	1984-01-27	1987-10-13	E. I. Du Pont De Nemours And Company	Nonradiometric polynucleotide probes
EP0170652A4 (de) *	1984-01-27	1988-08-23	Molecular Biosystems Inc	Test für immobilisierte reportergruppen.
US4849505A (en) *	1984-01-30	1989-07-18	Enzo Biochem, Inc.	Detectable molecules, method of preparation and use
US4849208A (en) *	1984-01-30	1989-07-18	Enzo Biochem, Inc.	Detectable molecules, method of preparation and use
US4707440A (en) *	1984-01-30	1987-11-17	Enzo Biochem, Inc.	Nucleic acid hybridization assay and detectable molecules useful in such assay
US5002885A (en) *	1984-01-30	1991-03-26	Enzo Biochem, Inc.	Detectable molecules, method preparation and use
US4943523A (en) *	1984-01-30	1990-07-24	Enzo Biochem, Inc.	Detectable molecules, method of preparation and use
US4843122A (en) *	1984-01-30	1989-06-27	Enzo Biochem, Inc.	Detectable molecules, method of preparation and use
AU3844485A (en) *	1984-02-09	1985-08-15	Enzo Biochem Inc.	Heterologous detection of cabeled dna
US4617261A (en) *	1984-03-21	1986-10-14	Cetus Corporation	Process for labeling nucleic acids and hybridization probes
US4705886A (en) *	1984-03-21	1987-11-10	Cetus Corporation	Precursor to nucleic acid probe
US4582789A (en) *	1984-03-21	1986-04-15	Cetus Corporation	Process for labeling nucleic acids using psoralen derivatives
US4751313A (en) *	1984-03-21	1988-06-14	Cetus Corporation	Precursor to nucleic acid probe
US4803297A (en) *	1984-03-21	1989-02-07	Cetus Corporation	Carbamic acid ester useful for preparing a nucleic acid probe
CA1260372A (en) *	1984-04-27	1989-09-26	Elazar Rabbani	Hybridization method for the detection of genetic materials
US4766062A (en) *	1984-05-07	1988-08-23	Allied Corporation	Displacement polynucleotide assay method and polynucleotide complex reagent therefor
US4766064A (en) *	1984-05-07	1988-08-23	Allied Corporation	Displacement polynucleotide assay employing polyether and diagnostic kit
IL75020A (en) *	1984-05-10	1988-10-31	Abbott Lab	Biotin-antibiotin immunoassay for the detection of ligands
CA1253777A (en) *	1984-06-01	1989-05-09	Robert J. Carrico	Nucleic acid hybridization assay employing immobilized rna probes
JP2648082B2 (ja) *	1984-06-28	1997-08-27	株式会社日立製作所	核酸塩基検出方法
JPH0658368B2 (ja) *	1984-06-28	1994-08-03	株式会社日立製作所	核酸塩基検出装置
FR2567523B1 (fr) *	1984-07-12	1987-11-13	Pasteur Institut	Polynucleotides lies de facon covalente a un support solide, et procede pour leur obtention
DE3431536A1 (de) *	1984-08-28	1986-03-13	Boehringer Mannheim Gmbh, 6800 Mannheim	Derivatisierte nucleinsaeure-sequenz, verfahren zu deren herstellung sowie deren verwendung zum nachweis von nucleinsaeuren
US4563417A (en) *	1984-08-31	1986-01-07	Miles Laboratories, Inc.	Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4828979A (en) *	1984-11-08	1989-05-09	Life Technologies, Inc.	Nucleotide analogs for nucleic acid labeling and detection
US4754065A (en) *	1984-12-18	1988-06-28	Cetus Corporation	Precursor to nucleic acid probe
US4670379A (en) *	1984-12-19	1987-06-02	E. I. Du Pont De Nemours And Company	Polynucleotide hydridization assays employing catalyzed luminescence
US4824775A (en) *	1985-01-03	1989-04-25	Molecular Diagnostics, Inc.	Cells labeled with multiple Fluorophores bound to a nucleic acid carrier
ATE40572T1 (de) *	1985-01-10	1989-02-15	Molecular Diagnostics Inc	Photochemisches verfahren zum markieren von nucleinsaeuren zum nachweis in hybridisationsproben.
DE3570441D1 (en) *	1985-01-24	1989-06-29	Neopharmed Spa	Acylated derivatives of cytidine-diphosphate-choline, process for their preparation and their therapeutic use
US4735897A (en) *	1985-05-02	1988-04-05	Allied Corporation	Method and kit for detecting polyriboadenosine segments and messenger RNA
US4767699A (en) *	1985-05-02	1988-08-30	Allied Corporation	Diagnostic reagent, kit and method employing polynucleotide displacement, separation, enzymatic cleavage and adenosine phosphate detection
US4762779A (en) *	1985-06-13	1988-08-09	Amgen Inc.	Compositions and methods for functionalizing nucleic acids
US4739044A (en) *	1985-06-13	1988-04-19	Amgen	Method for derivitization of polynucleotides
US5273882A (en) *	1985-06-13	1993-12-28	Amgen	Method and kit for performing nucleic acid hybridization assays
US4780405A (en) *	1985-06-25	1988-10-25	Siska Diagnostics, Inc.	Carbonic anhydrase inhibitor-tagged nucleic acid probes
US4833251A (en) *	1985-06-25	1989-05-23	Siska Diagnostics, Inc.	Compounds for tagging nucleic acid probes
EP0209996A3 (de) *	1985-06-25	1987-09-02	Siska Diagnostics,Inc.	N4-(Amino-substituierte) Cytidin enthaltendes Nukleinsäuretestmittel
JPH0725788B2 (ja) *	1985-09-09	1995-03-22	帝人株式会社	オリゴまたはポリヌクレオチド
US5595908A (en) *	1985-09-26	1997-01-21	University Of Southern Mississipi	Piezoelectric device for detection of polynucleotide hybridization
US5093232A (en) *	1985-12-11	1992-03-03	Chiron Corporation	Nucleic acid probes
US4910300A (en) *	1985-12-11	1990-03-20	Chiron Corporation	Method for making nucleic acid probes
US4868105A (en) *	1985-12-11	1989-09-19	Chiron Corporation	Solution phase nucleic acid sandwich assay
US4822731A (en) *	1986-01-09	1989-04-18	Cetus Corporation	Process for labeling single-stranded nucleic acids and hybridizaiton probes
US5348855A (en) *	1986-03-05	1994-09-20	Miles Inc.	Assay for nucleic acid sequences in an unpurified sample
US5091519A (en) *	1986-05-01	1992-02-25	Amoco Corporation	Nucleotide compositions with linking groups
US4851331A (en) *	1986-05-16	1989-07-25	Allied Corporation	Method and kit for polynucleotide assay including primer-dependant DNA polymerase
CA1338457C (en)	1986-08-22	1996-07-16	Henry A. Erlich	Purified thermostable enzyme
GB8621337D0 (en) *	1986-09-04	1986-10-15	Agricultural Genetics Co	Non-radioactive nucleic acid hybridization probes
JPH0799353B2 (ja) *	1987-03-31	1995-10-25	株式会社島津製作所	塩基配列決定装置
US5384241A (en) *	1987-09-11	1995-01-24	Enzo Diagnostics, Inc.	Specific binding assay compound with inhibitive self-quenching characteristics
DE3813278A1 (de) *	1988-01-12	1989-07-20	Boehringer Mannheim Gmbh	Verfahren zum nachweis von nukleinsaeuren
DE3800644A1 (de) *	1988-01-12	1989-07-20	Boehringer Mannheim Gmbh	Verfahren zum hochspezifischen nachweis von nukleinsaeuren in loesung
US5354657A (en) *	1988-01-12	1994-10-11	Boehringer Mannheim Gmbh	Process for the highly specific detection of nucleic acids in solid
FR2627590A1 (fr) *	1988-02-24	1989-08-25	Ire Celltarg Sa	Sonde d'acides nucleiques comportant un nucleotide terminal modifie chimiquement en 5(prime) (oh) en vue de son marquage non radioactif et procedes de preparation
FR2680374B2 (fr) *	1988-03-25	1993-11-12	Bioprobe Systems Sa	Procede de coloration d'acides nucleiques detectes par marquage non radioactif et ensemble de reactifs pour la mise en óoeuvre de ce procede.
US5109124A (en) *	1988-06-01	1992-04-28	Biogen, Inc.	Nucleic acid probe linked to a label having a terminal cysteine
US5817797A (en) *	1988-06-01	1998-10-06	The United States Of America As Represented By The Department Of Health And Human Services	Sequencing DNA; a modification of the polymerase chain reaction
FR2632955B1 (fr) *	1988-06-20	1991-12-27	Oris Ind	Derives de nucleosides utilisables pour la synthese d'oligonucleotides marques, oligonucleotides obtenus a partir de ces derives et leur synthese
US5489507A (en) *	1988-11-30	1996-02-06	Perkin-Elmer Corporation	DNA detection by color complementation
DE3916595A1 (de) *	1989-05-22	1990-11-29	Boehringer Mannheim Gmbh	Verfahren zur nichtradioaktiven messung der nucleinsaeuresynthese in eukaryontischen zellen
EP0407816A3 (en) *	1989-07-14	1993-01-27	Abbott Laboratories	Base modified nucleosides
US6787338B2 (en) *	1990-06-04	2004-09-07	The University Of Utah	Method for rapid thermal cycling of biological samples
US5210015A (en) †	1990-08-06	1993-05-11	Hoffman-La Roche Inc.	Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5587472A (en) *	1991-08-13	1996-12-24	Bayer Corporation	Coumarin-labeled nucleoside 5'-triphosphates
JP3390468B2 (ja) *	1991-10-16	2003-03-24	バイエルコーポレーション	新規の無水混合物法による遺伝子プローブの結合方法
EP0625985B1 (de) *	1991-12-06	1997-06-11	University Of Miami	Verfahren und ringgeöffnetes purin zur markierung von polynukleotiden
US5710028A (en) *	1992-07-02	1998-01-20	Eyal; Nurit	Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor
DE4302459A1 (de) *	1993-01-29	1994-08-04	Bayer Ag	Sulfocumarinhaltige Nukleotide und deren Verwendung in Nachweisverfahren für Nukleinsäuren
US7713528B1 (en)	1993-02-18	2010-05-11	Enzo Therapeutics, Inc.	Method for in vivo delivery of active compounds using reagent conjugate
US5952172A (en)	1993-12-10	1999-09-14	California Institute Of Technology	Nucleic acid mediated electron transfer
US6071699A (en)	1996-06-07	2000-06-06	California Institute Of Technology	Nucleic acid mediated electron transfer
US5591578A (en) *	1993-12-10	1997-01-07	California Institute Of Technology	Nucleic acid mediated electron transfer
US5824473A (en) *	1993-12-10	1998-10-20	California Institute Of Technology	Nucleic acid mediated electron transfer
US5620850A (en)	1994-09-26	1997-04-15	President And Fellows Of Harvard College	Molecular recognition at surfaces derivatized with self-assembled monolayers
US6150510A (en) *	1995-11-06	2000-11-21	Aventis Pharma Deutschland Gmbh	Modified oligonucleotides, their preparation and their use
DE4438918A1 (de)	1994-11-04	1996-05-09	Hoechst Ag	Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
US5731153A (en) *	1996-08-26	1998-03-24	The Regents Of The University Of California	Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions
US5783387A (en) *	1995-02-06	1998-07-21	The Regents Of The University Of California	Method for identifying and quantifying nucleic acid sequence aberrations
EP0752474A1 (de)	1995-07-07	1997-01-08	Boehringer Mannheim Gmbh	Nukleinsäure, die eine CMP-N-Acetyl-Neuraminsäure kodiert und ihre Verwendung zur Herstellung von modifizierten Glykoproteine
US5989813A (en) *	1995-07-13	1999-11-23	Molecular Innovations, Inc.	Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles
WO1997003348A1 (en) *	1995-07-13	1997-01-30	Immunological Associates Of Denver	Self-contained device integrating nucleic acid extraction, amplification and detection
US6444423B1 (en)	1996-06-07	2002-09-03	Molecular Dynamics, Inc.	Nucleosides comprising polydentate ligands
DE19637042A1 (de)	1996-09-12	1998-03-19	Boehringer Mannheim Gmbh	Heterocyclische Verbindungen und deren Verwendung in der Detektion von Nucleinsäuren
US6096273A (en)	1996-11-05	2000-08-01	Clinical Micro Sensors	Electrodes linked via conductive oligomers to nucleic acids
US7045285B1 (en)	1996-11-05	2006-05-16	Clinical Micro Sensors, Inc.	Electronic transfer moieties attached to peptide nucleic acids
US7381525B1 (en)	1997-03-07	2008-06-03	Clinical Micro Sensors, Inc.	AC/DC voltage apparatus for detection of nucleic acids
US7160678B1 (en)	1996-11-05	2007-01-09	Clinical Micro Sensors, Inc.	Compositions for the electronic detection of analytes utilizing monolayers
US7014992B1 (en) *	1996-11-05	2006-03-21	Clinical Micro Sensors, Inc.	Conductive oligomers attached to electrodes and nucleoside analogs
US6013459A (en)	1997-06-12	2000-01-11	Clinical Micro Sensors, Inc.	Detection of analytes using reorganization energy
WO1999037819A2 (en)	1998-01-27	1999-07-29	Clinical Micro Sensors, Inc.	Amplification of nucleic acids with electronic detection
US6686150B1 (en)	1998-01-27	2004-02-03	Clinical Micro Sensors, Inc.	Amplification of nucleic acids with electronic detection
FR2780059B1 (fr)	1998-06-17	2002-10-11	Bio Merieux	Procede de marquage d'un acide ribonucleique et fragments d'arn marques ainsi obtenus
US6290839B1 (en)	1998-06-23	2001-09-18	Clinical Micro Sensors, Inc.	Systems for electrophoretic transport and detection of analytes
US6761816B1 (en)	1998-06-23	2004-07-13	Clinical Micro Systems, Inc.	Printed circuit boards with monolayers and capture ligands
US7087148B1 (en)	1998-06-23	2006-08-08	Clinical Micro Sensors, Inc.	Binding acceleration techniques for the detection of analytes
US6335432B1 (en) *	1998-08-07	2002-01-01	Bio-Red Laboratories, Inc.	Structural analogs of amine bases and nucleosides
US6740518B1 (en)	1998-09-17	2004-05-25	Clinical Micro Sensors, Inc.	Signal detection techniques for the detection of analytes
WO2000024941A1 (en)	1998-10-27	2000-05-04	Clinical Micro Sensors, Inc.	Detection of target analytes using particles and electrodes
US20020146728A1 (en)	1998-12-03	2002-10-10	Tanja Ligensa	IGF-1 receptor interacting proteins
EP1006184A1 (de)	1998-12-03	2000-06-07	F. Hoffmann-La Roche Ag	Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs), Gene, die für diese kodieren, und deren Verwendungen
US6833267B1 (en)	1998-12-30	2004-12-21	Clinical Micro Sensors, Inc.	Tissue collection devices containing biosensors
US20020177135A1 (en)	1999-07-27	2002-11-28	Doung Hau H.	Devices and methods for biochip multiplexing
US7312087B2 (en)	2000-01-11	2007-12-25	Clinical Micro Sensors, Inc.	Devices and methods for biochip multiplexing
US6942771B1 (en)	1999-04-21	2005-09-13	Clinical Micro Sensors, Inc.	Microfluidic systems in the electrochemical detection of target analytes
US6593464B1 (en)	1999-05-24	2003-07-15	Invitrogen Corporation	Method for deblocking of labeled oligonucleotides
WO2000077179A2 (en)	1999-06-16	2000-12-21	Icos Corporation	Human poly(adp-ribose) polymerase 2 materials and methods
AU779220B2 (en)	1999-07-26	2005-01-13	Clinical Micro Sensors, Inc.	Sequence determination of nucleic acids using electronic detection
US6613516B1 (en)	1999-10-30	2003-09-02	Affymetrix, Inc.	Preparation of nucleic acid samples
EP1099757B1 (de)	1999-11-11	2010-02-24	F. Hoffmann-La Roche Ag	Verfahren zur Bestimmung von CTp11 sowie zur Bestimmung des metastatischen Potentials einer Tumor Probe
US6489114B2 (en)	1999-12-17	2002-12-03	Bio Merieux	Process for labeling a ribonucleic acid, and labeled RNA fragments which are obtained thereby
US6902891B2 (en)	1999-12-17	2005-06-07	Bio Merieux	Process for labeling a nucleic acid
EP1111069A1 (de) *	1999-12-22	2001-06-27	BioChip Technologies GmbH	Modifizierte Nukleinsäuren und deren Verwendung
JP2001288197A (ja)	2000-04-10	2001-10-16	Fuji Photo Film Co Ltd	蛍光ヌクレオチド
US6753143B2 (en)	2000-05-01	2004-06-22	Clinical Micro Sensors, Inc.	Target analyte detection using asymmetrical self-assembled monolayers
JP2004500852A (ja)	2000-05-19	2004-01-15	エフ．　ホフマン−ラ　ロシュ　アーゲー	ヒト腫瘍細胞においてダウンレギュレートされる核酸の使用による、試料の殺腫瘍能を決定するためのプロセス
US7338805B2 (en)	2001-05-04	2008-03-04	Bio Merieux	Labeling reagents, methods for synthesizing such reagents and methods for detecting biological molecules
US7060441B2 (en)	2001-05-04	2006-06-13	Biomerieux	Method for fragmenting and labeling DNA involving abasic sites and phosphate labeling
GB0112868D0 (en)	2001-05-25	2001-07-18	Secr Defence	Detection system
US6893822B2 (en)	2001-07-19	2005-05-17	Nanogen Recognomics Gmbh	Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
US7776524B2 (en)	2002-02-15	2010-08-17	Genzyme Corporation	Methods for analysis of molecular events
US7622544B2 (en)	2002-11-29	2009-11-24	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Process for preparation of biodegradable polymers and resins from proteins, and plastics obtained thereby
US7947817B2 (en)	2003-06-30	2011-05-24	Roche Molecular Systems, Inc.	Synthesis and compositions of 2'-terminator nucleotides
FR2868071B1 (fr)	2004-03-26	2006-06-09	Biomerieux Sa	Reactifs de marquage, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
EP1756313B1 (de) *	2004-06-14	2012-06-06	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Sequenzspezifischer nachweis der methylierung in biomolekülen
US7928207B2 (en) *	2004-06-28	2011-04-19	Roche Molecular Systems, Inc	Synthesis and compositions of nucleic acids comprising 2′-terminator nucleotides
US7745125B2 (en)	2004-06-28	2010-06-29	Roche Molecular Systems, Inc.	2′-terminator related pyrophosphorolysis activated polymerization
WO2006026654A2 (en)	2004-08-27	2006-03-09	Exact Sciences Corporation	Method for detecting a recombinant event
US9109256B2 (en)	2004-10-27	2015-08-18	Esoterix Genetic Laboratories, Llc	Method for monitoring disease progression or recurrence
JPWO2006098464A1 (ja)	2005-03-14	2008-08-28	リンク・ジェノミクス株式会社	前立腺がんの診断方法
US9777314B2 (en)	2005-04-21	2017-10-03	Esoterix Genetic Laboratories, Llc	Analysis of heterogeneous nucleic acid samples
WO2006119266A2 (en)	2005-04-29	2006-11-09	Rockefeller University	Human micrornas and methods for inhibiting same
FR2886735B1 (fr)	2005-06-01	2015-09-11	Biomerieux Sa	Procede de marquage ou de traitement d'un echantillon biologique contenant des molecules biologiques d'interet, notamment des acides nucleiques
JP2007215496A (ja) *	2006-02-17	2007-08-30	Filgen Inc	核酸解析法におけるプローブ核酸の蛍光標識方法
EP2028272B1 (de)	2006-06-06	2014-01-08	Panasonic Corporation	Verfahren zur modifizierung einer nukleotidkette
FR2917090B1 (fr)	2007-06-11	2012-06-15	Biomerieux Sa	Reactifs de marquage portant des fonctions diazo et nitro, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
FR2934595B1 (fr)	2008-07-29	2013-04-05	Biomerieux Sa	Reactifs de marquage ayant un noyau pyridine portant une fonction diazomethyle, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
JP2011529708A (ja)	2008-08-04	2011-12-15	ユニバーシティオブマイアミ	自然免疫応答の調節因子ｓｔｉｎｇ（インターフェロン遺伝子の刺激因子）
CN102341696B (zh)	2009-03-03	2013-12-11	万迈医疗仪器有限公司	用于高灵敏度荧光分析的检测系统和方法
US7928067B2 (en)	2009-05-14	2011-04-19	Ischemix Llc	Compositions and methods for treating ischemia and ischemia-reperfusion injury
US9216189B2 (en)	2010-01-25	2015-12-22	Icahn School Of Medicine At Mount Sinai	Antibodies which bind type I cannabinoid receptor/angiotensis II receptor heteromers
US8815937B2 (en)	2010-11-18	2014-08-26	Ischemix Llc	Lipoyl compounds and their use for treating ischemic injury
FR2968302B1 (fr)	2010-12-06	2012-11-30	Biomerieux Sa	Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
CN105181659A (zh)	2011-04-20	2015-12-23	万迈医疗仪器有限公司	发光聚合物循环扩增
WO2013123305A1 (en)	2012-02-16	2013-08-22	The Penn State Research Foundation	Modulators of acyl-coa lysocardiolipin acyltransferase 1 ( alcat1) and uses thereof
US9568431B2 (en)	2012-04-16	2017-02-14	Access Medical Systems, Ltd.	Luminescent immunoassays for quantitating analytes having a wide concentration range
FR2994184B1 (fr)	2012-08-02	2017-12-08	Biomerieux Sa	Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
US20150209406A1 (en)	2012-09-07	2015-07-30	Massachusetts Eye And Ear Infirmary	Methods and compositions for regenerating hair cells and/or supporting cells
CA2964234A1 (en)	2014-10-10	2016-04-14	Massachusetts Eye And Ear Infirmary	Efficient delivery of therapeutic molecules in vitro and in vivo
US10258697B2 (en)	2014-10-29	2019-04-16	Massachusetts Eye And Ear Infirmary	Efficient delivery of therapeutic molecules in vitro and in vivo
US11370823B2 (en)	2014-10-29	2022-06-28	Massachusetts Eye And Ear Infirmary	Efficient delivery of therapeutic molecules to cells of the inner ear
AU2018258158A1 (en)	2017-04-25	2019-11-21	Ischemix Llc	Compositions and methods for treating traumatic brain injury

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN142734B (de) *	1975-04-28	1977-08-20	Miles Lab
CA1219824A (en) *	1981-04-17	1987-03-31	David C. Ward	Modified nucleotides and methods of preparing and using same
FR2519004B1 (fr) *	1981-12-29	1985-09-27	Pasteur Institut	Acide adenosine 5'-triphosphorique modifie et procede de dosage de substances biologiques susceptibles de fixer des produits de degradation de l'acide adenosine 5'-triphosphorique
FR2519005B1 (fr) *	1981-12-29	1985-10-25	Pasteur Institut	Fragments d'adn marques a l'une au moins de leurs extremites par des ribonucleotides modifies reconnaissables par des molecules affines et procede pour realiser une analyse de tels fragments d'adn

1982
- 1982-03-15 CA CA000398359A patent/CA1219824A/en not_active Expired
- 1982-04-06 IL IL65447A patent/IL65447A/xx unknown
- 1982-04-06 DE DE8282301804T patent/DE3280032D1/de not_active Expired
- 1982-04-06 EP EP82301804A patent/EP0063879B1/de not_active Expired
- 1982-04-06 DE DE3280478T patent/DE3280478T2/de not_active Expired - Lifetime
- 1982-04-06 AT AT89106206T patent/ATE167189T1/de not_active IP Right Cessation
- 1982-04-13 AU AU82573/82A patent/AU560651B2/en not_active Expired
- 1982-04-16 DK DK171382A patent/DK164407B/da not_active IP Right Cessation
- 1982-04-16 JP JP57064611A patent/JPS57209297A/ja active Granted
1987
- 1987-04-03 JP JP62083703A patent/JPH0694474B2/ja not_active Expired - Lifetime
1990
- 1990-01-18 JP JP2010469A patent/JPH03261798A/ja active Pending
1991
- 1991-09-16 DK DK160591A patent/DK171822B1/da not_active IP Right Cessation
1992
- 1992-06-24 JP JP4166268A patent/JPH0880B2/ja not_active Expired - Lifetime
1997
- 1997-04-28 DK DK046797A patent/DK46797A/da not_active Application Discontinuation
- 1997-04-28 JP JP11100397A patent/JP3279503B2/ja not_active Expired - Lifetime
- 1997-04-28 JP JP11100297A patent/JP3279502B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPS57209297A (en)	1982-12-22
AU8257382A (en)	1982-10-21
JP3279502B2 (ja)	2002-04-30
IL65447A (en)	1987-01-30
JPS6399093A (ja)	1988-04-30
CA1219824A (en)	1987-03-31
DK46797A (da)	1997-04-28
AU560651B2 (en)	1987-04-16
DE3280032D1 (en)	1989-12-28
DK171822B1 (da)	1997-06-23
JPH07107998A (ja)	1995-04-25
JP3279503B2 (ja)	2002-04-30
JPH03261798A (ja)	1991-11-21
JPH0375559B2 (de)	1991-12-02
DK160591A (da)	1991-09-16
DE3280478D1 (de)	1998-07-16
DK171382A (da)	1982-10-18
JPH1033199A (ja)	1998-02-10
JPH0880B2 (ja)	1996-01-10
IL65447A0 (en)	1982-07-30
EP0063879B1 (de)	1989-11-23
JPH0694474B2 (ja)	1994-11-24
JPH1052271A (ja)	1998-02-24
ATE167189T1 (de)	1998-06-15
DK160591D0 (da)	1991-09-16
EP0063879A2 (de)	1982-11-03
EP0063879A3 (en)	1983-08-10
DE3280478T2 (de)	1999-02-18

Legal Events

Date	Code	Title
1992-09-18	PPF	Opposition filed
1992-09-22	PPF	Opposition filed
1996-10-07	B1	Patent granted (law 1993)
1999-02-08	PPF	Opposition filed
1999-04-12	PDU	Decision on opposition: patent maintained as unamended
2002-04-29	PUP	Patent expired

Publication	Publication Date	Title
DK164407B (da)	1992-06-22	Modificerede nucleotider og fremgangsmaader til deres fremstilling, fremgangsmaade til paavisning af et dobbeltstrenget polynucleotidduplex indeholdende et modificeret nucleotid, fremgangsmaade til bestemmelse af tilstedevaerelsen af et deoxyribonucleinsyremolekyle eller et ribonucleinsyremolekyle, fremgangsmaade til test af en bakterie, fremgangsmaade til diagnosticering af en genetisk forstyrrelse, fre
US5328824A (en)	1994-07-12	Methods of using labeled nucleotides
EP0457824B1 (de)	1999-06-23	Nachweis einer nukleinsäuresequenz oder einer änderung darin
US5102784A (en)	1992-04-07	Restriction amplification assay
US6090592A (en)	2000-07-18	Method for performing amplification of nucleic acid on supports
US5856092A (en)	1999-01-05	Detection of a nucleic acid sequence or a change therein
EP0382433B1 (de)	1997-11-05	Nachweis von Nukleinsäuresequenzen unter Verwendung von Fluoreszenz-Polarisation
US5641658A (en)	1997-06-24	Method for performing amplification of nucleic acid with two primers bound to a single solid support
US6048687A (en)	2000-04-11	Cycling DNA/RNA amplification electrochemiluminescent probe assay
US5427911A (en)	1995-06-27	Coupled amplification and sequencing of DNA
AU599628B2 (en)	1990-07-26	Amplified hybridization assay
KR101590220B1 (ko)	2016-01-29	유일 특이적 핵산 프로브 제조 방법
EP0329198B1 (de)	1998-06-10	Basenmodifizierte Oligo- und Polynucleotide und Verfahren zu ihrer Herstellung und Verwendung
JPH08511425A (ja)	1996-12-03	磁気サイクル反応
IE902390A1 (en)	1991-06-19	Hydrophobic nucleic acid probe
JPH08501220A (ja)	1996-02-13	Ｎｅｉｓｓｅｒｉａｇｏｎｏｒｒｈｏｅａｅ同定用の単離されたヌクレオチド配列
US6468751B1 (en)	2002-10-22	Method and apparatus for performing amplification of nucleic acid on supports
JP2540482B2 (ja)	1996-10-02	ポリヌクレオチド配列の生体内標識化
WO1990008838A1 (en)	1990-08-09	Labeling of nucleic acids with fluorescent markers
Hilborne et al.	1991	Diagnostic applications of recombinant nucleic acid technology: basic techniques